Chimeres Endolysin-Polypeptid
EP4775590
15. Juli 2026
Anmelder: Micreos Pharmaceuticals AG 🇨🇭
Details
- Veröffentlichungs-Nr.
- EP4775590
- Anmeldetag
- 22. Dezember 2023
- Veröffentlichung
- 15. Juli 2026
- Rechtsraum
- EP
- IPC
- C07K14/31
Abstract
The invention relates to the field of medicine, specifically to the field of treatment of conditions associated with Staphylococcus infection. The invention relates to a novel endolysin polypeptide specifically targeting a bacterial Staphylococcus cell. The invention further relates to said endolysin polypeptide for medical use, preferably for treating an individual suffering from a condition associated with Staphylococcus infection.
Anmelder
- Firma
- Micreos Pharmaceuticals AG
- Land
- 🇨🇭 Schweiz